Sai Life Sciences Ltd
NSE: SAILIFE BSE: 544306
₹972
(-1.40%)
Sun, 05 Apr 2026, 05:52 am
Market Cap205.53B
PE Ratio62.27
Dividend0
Commercial Services
Miscellaneous Commercial Services
24.5KSai Life Sciences Cashflow
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Deprecation and amortization | -901.61M | -994.32M | -1.19B | -1.39B |
| Accumulated depreciation, total | -1.76B | -2.31B | -3.02B | -3.81B |
| Cash from operating activities | 721.10M | 1.73B | 2.15B | 2.77B |
| Funds from operations | 966.60M | 1.38B | 2.54B | 4.09B |
| Net income (cash flow) | 62.26M | 99.89M | 828.09M | 1.70B |
| Depreciation & amortization (cash flow) | 901.61M | 994.32M | 1.19B | 1.39B |
| Depreciation/depletion | 869.20M | 948.59M | 1.11B | 1.29B |
| Amortization | 32.41M | 45.73M | 87.67M | 96.19M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 |
| Non-cash items | -31.96M | 225.66M | 248.61M | 422.60M |
| Changes in working capital | -245.50M | 349.26M | -382.42M | -1.31B |
| Cash from investing activities | -1.13B | -1.10B | -2.05B | -5.53B |
| Capital expenditures | -2.07B | -1.13B | -1.82B | -3.69B |
| Capital expenditures - fixed assets | -2.07B | -1.13B | -1.82B | -3.69B |
| Capital expenditures - other assets | — | — | — | — |
| Cash from financing activities | 1.14B | -1.46B | -353.26M | 3.54B |
| Free cash flow | -1.35B | 602.57M | 335.99M | -918.36M |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800